Table 2 Comparison of homocysteine, nitric oxide levels and lipid profiles between the exposed women to LD pills vs. non-exposed ones
The risk factors of cardiovascular diseases | The users of LD pills (n = 50) | The non-users of LD pills (n = 50) | P- value |
|---|---|---|---|
Homocysteine levels (μmol/l) | 3.848 ± 2.357 | 3.284 ± 1.616 | 0.41 |
Nitric oxide (μM) | 181.360 ± 90.44 | 162.654 ± 90.913 | 0.29 |
Cholesterol (mg/dl) | 180.7 ± 38.28 | 159.74 ± 30.26 | 0.00 |
HDL-c (mg/dl) | 56.46 ± 8.42 | 56.18 ± 8.91 | 0.87 |
LDL-c (mg/dl) | 101.42 ± 30.66 | 84.84 ± 24.70 | 0.00 |
Triglyceride (mg/dl) | 129.82 ± 47.92 | 93.60 ± 44.01 | 0.00 |